1. Home
  2. Browse
  3. Drug Information

Drug Information

1471 - 1485 of 2200 Results
Sort Results:
Guideline: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. June 2008
Commentary: New Drug: Cimzia (Certolizumab Pegol) June 2008
Commentary: New Formulation: Treximet (Sumatriptan and Naproxen) for Migraine June 2008
Commentary: Omnaris (Ciclesonide) and Patanase (Olopatadine): New Nasal Sprays for Allergic Rhinitis June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Guideline: Perianal Crohn’s Disease (2003) June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity June 2008
Guideline: Prevention of Migraine (US Headache Consortium) (2000) June 2008
Guideline: Resistant Hypertension: Diagnosis, Evaluation, and Treatment June 2008
Guideline: Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache (AAFP/ACP-ASIM) (2002) June 2008
Guideline: Type 2 Diabetes in Children and Adolescents June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008
Guideline: Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease [Summary] (2006) June 2008
Guideline: Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents June 2008